<DOC>
	<DOCNO>NCT02770287</DOCNO>
	<brief_summary>The study confirm Freeze Diamond polar applicator safe treat Mons pubis Labia , result improvement general skin appearance include improvement skin irregularity skin laxity .</brief_summary>
	<brief_title>Radiofrequency Pulsed Electromagnetic Field Treatment Skin Laxity Mon Pubis , Labia Vaginal Introitus</brief_title>
	<detailed_description>This single-center , open-label , prospective study . Ten ( 10 ) subject meet inclusion criterion enrol site 's pool patient . Subjects female age 25-65 , suitable treatment area ( e.g . skin irregularity and/or unwanted skin laxity Mons pubis , Introitus and/or Labia area ) . Subjects receive three treatment study device , four week interval , follow one month follow-up visit last treatment .</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<criteria>1 . Healthy female age 25 65 . 2 . Able read , understand voluntarily provide write Informed Consent ; 3 . Able willing comply treatment/followup schedule requirement ; 4 . Fitzpatrick skin type IVI . 5 . Sexual activity ( vaginal intercourse per month ) monogamous relationship . 6 . Women childbearing age require use reliable method birth control least 3 month prior study enrollment , negative Urine Pregnancy test baseline . 7 . Women request aesthetic benefit vaginal mon , introitus labium . 1 . Pregnant intend become pregnant course study . A urine pregnancy test give woman childbearing potential perform initial visit . 2 . Having active electrical implant anywhere body , pacemaker internal defibrillator . 3 . Having permanent implant treat area . 4 . Prior use retinoids treat area within 2 week initial treatment course study . 5 . Use oral Isotretinoin ( AccutaneÂ® ) within 6 month initial treatment course study . 6 . Patient systemic corticosteroid therapy 6 month prior throughout course study . 7 . Prior skin treatment laser treat area within 6 month initial treatment course study . 8 . Prior use collagen , fat injection /or method skin augmentation ( enhancement inject implanted material ) treat area within 46 week initial treatment course study . Treatment may perform permanent dermal implant . 9 . Prior ablative resurfacing procedure treat area laser device within 12 month initial treatment course study . 10 . Any surgery treat area within 12 month initial treatment course study . 11 . History keloid formation poor wound heal previously injure skin area . 12 . History epidermal dermal disorder ( particularly involve collagen microvascularity ) . 13 . Open laceration abrasion sort area treat . 14 . Active sexually transmit disease ( e.g . genital Herpes Simplex , condylomata ) vaginosis ; tissue biopsy defer delay later time point infection resolve . 15 . Chronic vulvar pain vulvar dystrophy . 16 . History immunosuppression/immune deficiency disorder ( include human immunodeficiency virus infection acquire immune deficiency syndrome ) use immunosuppressive medication . 17 . Having form active cancer time enrollment course study . 18 . Significant concurrent illness , uncontrolled diabetes i.e . disease state opinion Investigator would interfere treatment , heal process . 19 . Participation study another device drug within 1 month prior study enrollment study , per Investigator 's careful discretion , long contradictory criterion . 20 . Tattoos treatment area . 21 . Mentally incompetent , prisoner evidence active substance alcohol abuse . 22 . Having stage 34 cystocele , rectocele , enterocele paravaginal defect major pelvic organ prolapse beyond hymenal ring .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>